Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.
作者： Beuy Joob , Viroj Wiwanitkit
DOI: 10.1136/ANNRHEUMDIS-2020-217695
关键词:
摘要: We thank the readers who share interesting ideas on our publication entitled ‘SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment’.1 First, we really appreciate reply by Monti Montecucco.2 agree that large registry data are required to clarify incidence of COVID-19 in systemic lupus erythematosus (SLE).1 Seeking for new drug against emerging is challenge. In this pandemic situation, urgent search vaccine necessary. Not only but also other drugs such as antiretroviral widely used without complete clinical trials. feel glad article can stimulate sharing important issue inter-relationship between COVID-19, …
scilit.net参考文章(8)
Sara Monti, Silvia Balduzzi, Paolo Delvino, Elisa Bellis, Verdiana Serena Quadrelli, Carlomaurizio Montecucco, Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Annals of the Rheumatic Diseases. ,vol. 79, pp. 667- 668 ,(2020) , 10.1136/ANNRHEUMDIS-2020-217424
Kaleb Michaud, Kristin Wipfler, Yomei Shaw, Teresa A. Simon, Adam Cornish, Bryant R. England, Alexis Ogdie, Patricia Katz, Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR Open Rheumatology. ,vol. 2, pp. 335- 343 ,(2020) , 10.1002/ACR2.11148
Beuy Joob, Viroj Wiwanitkit, SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment. Annals of the Rheumatic Diseases. ,vol. 79, ,(2020) , 10.1136/ANNRHEUMDIS-2020-217506
Amr H Sawalha, Patients with lupus are not protected from COVID-19. Annals of the Rheumatic Diseases. ,vol. 80, ,(2021) , 10.1136/ANNRHEUMDIS-2020-217656
Sara Monti, Carlomaurizio Montecucco, Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit. Annals of the Rheumatic Diseases. ,vol. 79, ,(2020) , 10.1136/ANNRHEUMDIS-2020-217524
Mohit Goyal, SLE patients are not immune to covid-19: importance of sending the right message across. Annals of the Rheumatic Diseases. ,vol. 80, ,(2021) , 10.1136/ANNRHEUMDIS-2020-217658
Alexis Mathian, Matthieu Mahevas, Julien Rohmer, Mathilde Roumier, Fleur Cohen-Aubart, Blanca Amador-Borrero, Audrey Barrelet, Cecile Chauvet, Thibaud Chazal, Michel Delahousse, Mathilde Devaux, Romain Euvrard, Jehane Fadlallah, Nans Florens, Julien Haroche, Miguel Hié, Laurent Juillard, Raphael Lhote, Thibault Maillet, Gaelle Richard-Colmant, Jean Baptiste Palluy, Micheline Pha, Laurent Perard, Philippe Remy, Etienne Rivière, Damien Sène, Pascal Sève, Capucine Morélot-Panzini, Jean-François Viallard, Jean-Simon Virot, Neila Benameur, Noël Zahr, Hans Yssel, Bertrand Godeau, Zahir Amoura, Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Annals of the Rheumatic Diseases. ,vol. 79, pp. 837- 839 ,(2020) , 10.1136/ANNRHEUMDIS-2020-217566
Vasco C. Romão, Ana Rita Cruz-Machado, João Eurico Fonseca, No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19 : comment by Joob and Wiwanitkit Annals of the Rheumatic Diseases. ,vol. 80, ,(2021) , 10.1136/ANNRHEUMDIS-2020-217665